Sunpeaks Ventures Inc (OTC:SNPK): Rally Going on, Up 368% In 20 Sessions
It has been solid past few trading weeks for investors of Sunpeaks Ventures Inc(OTC:SNPK) as the stock has been soaring since the beginning of mid March and recorded a gain of about 368% in just twenty trading sessions.
The stock started to move up on March 19, 2012, when it closed higher by 12.50%. The stock quickly moved up to $1 as of April 04, 2012, breaching its key psychological barrier. Then stock moved from $1 to $2 in just 8 trading session and made an all-time high of $2.25 in today’s session.
So what’s driving the stock? First on March 26, 2012, Sunpeaks announced to launch its Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, at select Bravo Supermarkets in South Florida in the next few weeks.
Last week, the company’s wholly owned subsidiary, Healthcare Distribution Specialists LLC (HDS) announced its effort to increase its promotional activities by signing a deal with another major sports team to promote Clotamin®.
Late Monday, the company and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”) are pleased to announce that HDS will be an official exhibitor at the Thrombosis and Hemostasis Summit of North America (the “THSNA”) to be held May 3-5, 2012 at the Hyatt Regency Chicago.
The stock is now trading higher by 14.29% to $2.24 on hefty volume of 15.83 million shares so far, compared to its average volume of 25.79 million. Interestingly, the stock closed lower in just three trading sessions out of past nineteen trading sessions.
So what’s next? Well it’s quite difficult to predict where the stock is heading, but considering the recent quick run up, investors must be careful before talking any long position in the stock. Penny stocks carry very high risk as well as very high returns. Undoubtedly, so far SNPK has proven worth taking risk, but keep your eyes on SNPK, where the stock could go from here on.